AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML)
udgivet i: Blood
dato for udgivelse: 2009-08-04
sprog: engelsk
main subject: quizartinib, leukæmi, akut myeloid leukæmi, childhood acute myeloid leukemia
Cites articles 50
- 2005-08-01
- 2005-08-01
Date
Titel
Artikel - wd:Q37373040